Genius Completes the Acquisition of all the Assets of Reiva

MONTREAL, QUEBEC--(Marketwired - May 26, 2015) - Genius Properties Ltd. ("Genius" or the "Corporation") (CSE:GNI) is pleased to announce that further to its news release of May 21, 2015, it has completed the arms-length acquisition of all the assets of Reïva, composed primarily of a portfolio of proprietary brands and exclusive recipes of natural and functional beverages and related products.

Principal Terms of Transaction

Under the terms of the transaction, Genius will issue to Reïva an aggregate thirty million (30,000,000) new common shares (the "Consideration Shares") from the Corporation's share capital. The Consideration Shares will be subject to a thirty-six (36) month escrow, in accordance with CSE policies and applicable securities regulation.

Denis Richard, the founder of Reïva, is officially named President and Chief Executive Officer of Genius and Stéphane Leblanc is named Executive Vice-President and Secretary. Mr. Leblanc also remain as a Director of the Corporation.

In connection with the transaction, finder's fees totaling 1,400,000 shares will be issued by Genius to a non-arm's length party who was specifically commissioned and without whom the transaction would otherwise not have been entered into. The Shares issued as finder's fees will be subject to a twelve (12) month escrow, in accordance with CSE policies and applicable securities regulation.

About Reïva

Reïva has developed a range of world class exclusive products, a "next generation" of natural and functional beverages and related products. Its founder's primary objective is to offer a healthier lifestyle to consumers. When Denis Richard started developing world class exclusive formulas, he addressed the problems at their source, in collaboration with universities and independent laboratories. The Reïva team is committed to producing safe and efficient products designed to fill the void in the industry by offering consumers products focused on health and wellness. The team's devotion is supported by several pending patent applications.